IP Library Granted Patent US 8,600,681
Granted Patent B2
US 8,600,681 · App. 12/152,648 · Granted Dec 3, 2013

Method and apparatus for providing data processing and control in a medical communication system

Inventors: Gary Hayter (Oakland, CA); Geoffrey V. McGarraugh (Oakland, CA); Andrew H. Naegeli (Walnut Creek, CA); John C. Mazza (Pleasanton, CA); Benjamin J. Feldman (Oakland, CA)
Assignee: Abbott Diabetes Care Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,600,681
App. No.
12/152,648
Granted
Dec 3, 2013
Kind
B2
Abstract

Methods and apparatus for providing data processing and control for use in a medical communication system are provided.

Claims (39)

1. A computer-implemented method to determine a composite sensitivity of an in vivo analyte sensor, comprising:

receiving, at one or more processors, a calibration parameter to calibrate the in vivo analyte sensor;

determining, using the one or more processors, a sensitivity value associated with the received calibration parameter;

retrieving, using the one or more processors, a prior sensitivity value associated with the in vivo analyte sensor;

comparing, using the one or more processors, the determined sensitivity value and the retrieved prior sensitivity value;

determining, using the one or more processors, if the comparison of the determined sensitivity value and the retrieved prior sensitivity value is within a predetermined range; and

determining, using the one or more processors, a composite sensitivity for the in vivo analyte sensor based on one or more of the received calibration parameter, the determined sensitivity value and the retrieved prior sensitivity value, if the comparison of the determined sensitivity value and the retrieved prior sensitivity value is within the predetermined range.

2. The method of claim 1 wherein the calibration parameter includes a blood glucose value.

3. The method of claim 1 wherein the retrieved prior sensitivity value is associated with a prior calibration parameter used to calibrate the in vivo analyte sensor.

4. The method of claim 3 wherein the prior calibration parameter includes a blood glucose value.

5. The method of claim 1 wherein determining the composite sensitivity includes applying a first weighted parameter to the determined sensitivity value and applying a second weighted parameter to the retrieved prior sensitivity value.

6. The method of claim 5 wherein the first weighted parameter and the second weighted parameter are different.

7. The method of claim 5 wherein the first weighted parameter and the second weighted parameter are substantially the same.

8. The method of claim 5 wherein the first weighted parameter and the second weighted parameter are time based.

9. The method of claim 8 wherein the prior sensitivity value associated with the in vivo analyte sensor is based on a prior calibration parameter used to calibrate the in vivo analyte sensor prior to a predetermined time period of receiving the calibration parameter.

10. The method of claim 8 wherein the first weighted parameter is associated with a current in vivo analyte sensor calibration event, and the second weighted parameter is associated with a prior in vivo analyte sensor calibration event.

11. The method of claim 1 wherein the in vivo analyte sensor comprises at least one working electrode including an analyte-responsive enzyme and a mediator, wherein at least one of the analyte-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode, and further wherein at least one of the analyte-responsive enzyme and the mediator is crosslinked with the polymer.

12. An apparatus, comprising:

an interface unit to receive one or more signals associated with a continuously monitored analyte level and a blood glucose value;

a processing unit coupled to the interface unit; and

a memory coupled to the processing unit for storing instructions which, when executed by the processing unit, causes the processing unit to determine a sensitivity value associated with a received blood glucose value, to retrieve a prior sensitivity value associated with an in vivo analyte sensor, to compare the determined sensitivity value and the retrieved prior sensitivity value, to determine if the comparison of the determined sensitivity value and the retrieved prior sensitivity value is within a predetermined range, and to determine a composite sensitivity based on the determined sensitivity value and the retrieved prior sensitivity value, if the comparison of the determined sensitivity value and the retrieved prior sensitivity value is within the predetermined range.

13. The apparatus of claim 12 wherein the retrieved prior sensitivity value is associated with a prior calibration parameter used to calibrate the in vivo analyte sensor.

14. The apparatus of claim 12 wherein the memory for storing instructions which, when executed by the processing unit, further causes the processing unit to apply a first weighted parameter to the determined sensitivity value and to apply a second weighted parameter to the retrieved prior sensitivity value.

15. The apparatus of claim 14 wherein the first weighted parameter and the second weighted parameter are different.

16. The apparatus of claim 12 wherein the prior sensitivity value associated with the in vivo analyte sensor is based on a prior calibration event to calibrate the in vivo analyte sensor prior to a predetermined time period of receiving the blood glucose value.

17. The apparatus of claim 12 including a display unit to display one or more information associated with the composite sensitivity, wherein the displayed one or more information associated with the composite sensitivity includes an in vivo analyte sensor calibration completion event.

18. The apparatus of claim 12 wherein the composite sensitivity is determined based on a weighted average of the determined sensitivity value and the prior sensitivity value associated with the in vivo analyte sensor.

19. The apparatus of claim 12 wherein the in vivo analyte sensor comprises at least one working electrode including an analyte-responsive enzyme and a mediator, wherein at least one of the analyte-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode, and further wherein at least one of the analyte-responsive enzyme and the mediator is crosslinked with the polymer.

20. A glucose monitoring system, comprising:

a transcutaneously positionable in vivo analyte sensor for monitoring an analyte level;

an analyte monitoring device coupled to the in vivo analyte sensor for receiving signals from the in vivo analyte sensor associated with the monitored analyte level; and

a data processing unit coupled to the analyte monitoring device, the data processing unit storing instructions which, when executed by the data processing unit, causes the data processing unit to determine a sensitivity value associated with a received blood glucose value, to retrieve a prior sensitivity value associated with the in vivo analyte sensor, to compare the determined sensitivity value and the retrieved prior sensitivity value, to determine if the comparison of the determined sensitivity value and the retrieved prior sensitivity value is within a predetermined range, and to determine a composite sensitivity based on the determined sensitivity value and the retrieved prior sensitivity value, if the comparison of the determined sensitivity value and the retrieved prior sensitivity value is within the predetermined range.

21. The system of claim 20 wherein the in vivo analyte sensor includes a glucose sensor.

22. The system of claim 20 wherein the data processing unit is in signal communication with the analyte monitoring device based on a predetermined communication protocol.

23. The system of claim 20 wherein the retrieved prior sensitivity value is associated with a prior calibration parameter used to calibrate the in vivo analyte sensor.

24. The system of claim 20 wherein the processing unit includes instructions which, when executed by the processing unit, further causes the processing unit to apply a first weighted parameter to the determined sensitivity value and to apply a second weighted parameter to the retrieved prior sensitivity value.

25. The system of claim 20 wherein the prior sensitivity value associated with the in vivo analyte sensor is based on a prior calibration event to calibrate the in vivo analyte sensor prior to a predetermined time period of receiving the blood glucose value.

26. The system of claim 20 wherein the composite sensitivity is determined based on a weighted average of the determined sensitivity value and the prior sensitivity value associated with the in vivo analyte sensor.

27. The system of claim 20 wherein the in vivo analyte sensor comprises at least one working electrode including an analyte-responsive enzyme and a mediator, wherein at least one of the analyte-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode, and further wherein at least one of the analyte-responsive enzyme and the mediator is crosslinked with the polymer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2008
From: HAYTER, GARY; MCGARRAUGH, GEOFFREY V.; NAEGELI, ANDREW H.; MAZZA, JOHN C.; FELDMAN, BENJAMIN J.
To: ABBOTT DIABETES CARE, INC.
Reel/Frame 021343/0410 →
Continuity (2)
Provisional Application 60917850 · May 14, 2007
Related Publication 20080287761A1 · Nov 20, 2008